Abris buys Polish healthcare business Scanmed

Abris to support healthcare network in the extension of its service offering and geographic coverage.

26 November 2020, Warsaw – Abris CEE Mid-Market III LP fund, managed by Abris Capital Partners (“Abris”), the leading private equity investor in Central Europe, has signed an agreement to acquire 100% of the shares in Scanmed S.A. (“Scanmed”) – a Poland-based healthcare network operator – from Life Healthcare Group Holdings Limited (“Life Healthcare”). The transaction is subject to regulatory approvals and is expected to close in the first quarter of 2021.

For more than a decade, Scanmed has offered its patients access to comprehensive treatment methods, technologically advanced and high-quality medical equipment and experienced specialists to facilitate their recovery. The company operates in 42 locations across Poland, providing primary healthcare and specialist consultations, advanced diagnostics and hospital treatment.

Abris was attracted to the healthcare sector by its strong fundamentals, underpinned by a rapidly ageing population in Poland and increasing healthcare spending aimed at improving the quality of service and the comprehensiveness of care.

Abris plans to support Scanmed in the extension of its service offering and geographic coverage, as well as in the continued improvement of its medical facilities and care in key therapeutic areas. The company also plans to increase commercial revenues in orthopedics, ophthalmology, rehabilitation and urogynecology, and to open new labs and surgery units.

At present, Scanmed operates two multi-specialist hospitals, 13 cardiac centers offering comprehensive diagnostics and cardiological treatment, and a variety of clinics and medical centers across Poland. Scanmed also provides outpatient care services in major Polish cities including Warsaw, Kraków, Poznan, Wroclaw, Gdansk and Pabianice.

Wojciech Łukawski, Partner at Abris Capital Partners, commented:

“We look forward to working hand in hand with Scanmed’s experienced management team and first-class medical personnel – the key asset of the group – in establishing the company as an institution of choice for Polish patients. We are also privileged to partner with a company that has provided such vital support in tackling the Covid-19 pandemic in Poland, in cooperation with public healthcare institutions.”

Abris’ previous investments in the healthcare sector include ITP S.A., a Polish vendor of innovative aesthetic medicine products, and Dentotal Protect, the leading distributor of dental consumables, instruments and equipment in Romania.

For more information:
Hydra Strategy (for Abris Capital)
Sam Barton

+44 (0)7380 961 549